603231 索宝蛋白
已收盘 01-13 15:00:00
资讯
新帖
简况
每周股票复盘：索宝蛋白（603231）2025中期拟每股派0.7元
证券之星 · 01-11 04:04
每周股票复盘：索宝蛋白（603231）2025中期拟每股派0.7元
索宝蛋白（603231）披露2025年中期利润分配方案，1月9日股价上涨0.38%
证券之星 · 01-09
索宝蛋白（603231）披露2025年中期利润分配方案，1月9日股价上涨0.38%
索宝蛋白（603231）披露2025年度持续督导现场检查报告，1月7日股价下跌0.11%
证券之星 · 01-07
索宝蛋白（603231）披露2025年度持续督导现场检查报告，1月7日股价下跌0.11%
索宝蛋白（603231）披露召开2026年第一次临时股东会通知，1月5日股价上涨0.82%
证券之星 · 01-05
索宝蛋白（603231）披露召开2026年第一次临时股东会通知，1月5日股价上涨0.82%
每周股票复盘：索宝蛋白（603231）拟每10股派0.70元
证券之星 · 01-02
每周股票复盘：索宝蛋白（603231）拟每10股派0.70元
每周股票复盘：索宝蛋白（603231）变更募投项目实施主体
证券之星 · 2025-12-28
每周股票复盘：索宝蛋白（603231）变更募投项目实施主体
索宝蛋白（603231）披露开立募集资金专项账户并签订四方监管协议公告，12月23日股价下跌0.32%
证券之星 · 2025-12-23
索宝蛋白（603231）披露开立募集资金专项账户并签订四方监管协议公告，12月23日股价下跌0.32%
12月8日索宝蛋白发布公告，股东减持29.8万股
证券之星 · 2025-12-08
12月8日索宝蛋白发布公告，股东减持29.8万股
索宝蛋白股东计划减持股份
投资观察 · 2025-11-20
索宝蛋白股东计划减持股份
索宝蛋白（603231）披露取消监事会及修改公司章程议案获通过，11月17日股价下跌0.71%
证券之星 · 2025-11-17
索宝蛋白（603231）披露取消监事会及修改公司章程议案获通过，11月17日股价下跌0.71%
每周股票复盘：索宝蛋白（603231）拟取消监事会并变更募投项目
证券之星 · 2025-11-16
每周股票复盘：索宝蛋白（603231）拟取消监事会并变更募投项目
索宝蛋白（603231）披露股东减持股份计划公告，11月12日股价下跌1.77%
证券之星 · 2025-11-12
索宝蛋白（603231）披露股东减持股份计划公告，11月12日股价下跌1.77%
索宝蛋白(603231.SH)：济南复星、宁波复星拟合计减持不超3%股份
智通财经 · 2025-11-11
索宝蛋白(603231.SH)：济南复星、宁波复星拟合计减持不超3%股份
索宝蛋白（603231）披露拟取消监事会并变更部分募投项目，11月10日股价上涨1.88%
证券之星 · 2025-11-10
索宝蛋白（603231）披露拟取消监事会并变更部分募投项目，11月10日股价上涨1.88%
索宝蛋白：截至2025年10月31日，公司股东人数为17895户
证券日报 · 2025-11-04
索宝蛋白：截至2025年10月31日，公司股东人数为17895户
股市必读：索宝蛋白三季报 - 第三季度单季净利润同比增长135.87%
中金财经 · 2025-11-03
股市必读：索宝蛋白三季报 - 第三季度单季净利润同比增长135.87%
每周股票复盘：索宝蛋白（603231）Q3净利增135.87%
证券之星 · 2025-11-02
每周股票复盘：索宝蛋白（603231）Q3净利增135.87%
索宝蛋白(603231)9月30日股东户数1.9万户，较上期减少3.86%
证券之星 · 2025-10-31
索宝蛋白(603231)9月30日股东户数1.9万户，较上期减少3.86%
图解索宝蛋白三季报：第三季度单季净利润同比增长135.87%
证券之星 · 2025-10-31
图解索宝蛋白三季报：第三季度单季净利润同比增长135.87%
异动快报：索宝蛋白（603231）10月22日9点39分触及涨停板
证券之星 · 2025-10-22
异动快报：索宝蛋白（603231）10月22日9点39分触及涨停板
加载更多
公司概况
公司名称：
宁波索宝蛋白科技股份有限公司
所属行业：
农副食品加工业
上市日期：
2023-12-15
主营业务：
宁波索宝蛋白科技股份有限公司的主营业务是大豆蛋白系列产品的研发、生产和销售。公司的主要产品是大豆分离蛋白、大豆浓缩蛋白、组织化蛋白、大豆膳食纤维及非转基因大豆油。
发行价格：
21.29
{"stockData":{"symbol":"603231","market":"SH","secType":"STK","nameCN":"索宝蛋白","latestPrice":18.9,"timestamp":1768287601000,"preClose":18.75,"halted":0,"volume":4219747,"delay":0,"changeRate":0.008,"floatShares":106000000,"shares":191000000,"eps":0.9203,"marketStatus":"已收盘","change":0.15,"latestTime":"01-13 15:00:00","open":18.75,"high":19.09,"low":18.65,"amount":79899800,"amplitude":0.0235,"askPrice":18.9,"askSize":84,"bidPrice":18.89,"bidSize":20,"shortable":0,"etf":0,"ttmEps":0.9203,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1768354200000},"marketStatusCode":5,"adr":0,"adjPreClose":18.75,"symbolType":"stock","openAndCloseTimeList":[[1768267800000,1768275000000],[1768280400000,1768287600000]],"highLimit":20.63,"lowLimit":16.88,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":191459105,"isCdr":false,"pbRate":1.84,"roa":"--","peRate":20.536781,"roe":"7.66%","epsLYR":0.63,"committee":0.534653,"marketValue":3619000000,"turnoverRate":0.0397,"status":0,"floatMarketCap":2008000000},"requestUrl":"/m/hq/s/603231","defaultTab":"news","newsList":[{"id":"2602536455","title":"每周股票复盘：索宝蛋白（603231）2025中期拟每股派0.7元","url":"https://stock-news.laohu8.com/highlight/detail?id=2602536455","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602536455?lang=zh_cn&edition=full","pubTime":"2026-01-11 04:04","pubTimestamp":1768075451,"startTime":"0","endTime":"0","summary":"截至2026年1月9日收盘，索宝蛋白报收于18.73元，较上周的18.32元上涨2.24%。本周，索宝蛋白1月8日盘中最高价报18.75元。2025年中期利润分配方案拟以2025年末总股本191,459,105股为基数，向全体股东每10股派发现金股利0.70元（含税），合计分配利润13,402,137.35元（含税），该分红金额占2025年前三季度归属于母公司股东净利润的9.14%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011100001325.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0238","603231"],"gpt_icon":0},{"id":"2602372303","title":"索宝蛋白（603231）披露2025年中期利润分配方案，1月9日股价上涨0.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2602372303","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602372303?lang=zh_cn&edition=full","pubTime":"2026-01-09 22:47","pubTimestamp":1767970030,"startTime":"0","endTime":"0","summary":"截至2026年1月9日收盘，索宝蛋白报收于18.73元，较前一交易日上涨0.38%，最新总市值为35.86亿元。根据公告内容，该利润分配方案拟以2025年末总股本191,459,105股为基数，向全体股东每10股派发现金股利0.70元（含税），合计分配利润13,402,137.35元（含税）。现金分红占2025年前三季度归母净利润的9.14%。如股权登记日前公司总股本发生变动，将维持每股分配比例不变，相应调整分配总额。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010900041356.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603231","BK0238"],"gpt_icon":0},{"id":"2601801125","title":"索宝蛋白（603231）披露2025年度持续督导现场检查报告，1月7日股价下跌0.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601801125","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601801125?lang=zh_cn&edition=full","pubTime":"2026-01-07 22:34","pubTimestamp":1767796458,"startTime":"0","endTime":"0","summary":"截至2026年1月7日收盘，索宝蛋白报收于18.53元，较前一交易日下跌0.11%，最新总市值为35.48亿元。近日，东吴证券股份有限公司发布了关于宁波索宝蛋白科技股份有限公司2025年度持续督导工作现场检查报告。公告显示，东吴证券作为索宝蛋白首次公开发行股票并在主板上市的保荐人，于2025年12月29日至12月31日对索宝蛋白开展了2025年度持续督导现场检查。检查过程中未发现需向监管部门报告的重大事项。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010700039109.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603231","BK0238"],"gpt_icon":0},{"id":"2601913000","title":"索宝蛋白（603231）披露召开2026年第一次临时股东会通知，1月5日股价上涨0.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601913000","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601913000?lang=zh_cn&edition=full","pubTime":"2026-01-05 18:21","pubTimestamp":1767608473,"startTime":"0","endTime":"0","summary":"截至2026年1月5日收盘，索宝蛋白报收于18.47元，较前一交易日上涨0.82%，最新总市值为35.36亿元。该股当日开盘18.32元，最高18.5元，最低18.28元，成交额达4586.45万元，换手率为2.34%。近日，宁波索宝蛋白科技股份有限公司发布公告，宣布将于2026年1月16日召开2026年第一次临时股东会，会议采取现场投票与网络投票相结合方式。股权登记日为2026年1月9日。本次股东会将审议2025年中期利润分配方案及未来三年股东回报规划。中小投资者对上述两项议案将单独计票。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010500028595.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0238","603231"],"gpt_icon":0},{"id":"2600610039","title":"每周股票复盘：索宝蛋白（603231）拟每10股派0.70元","url":"https://stock-news.laohu8.com/highlight/detail?id=2600610039","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600610039?lang=zh_cn&edition=full","pubTime":"2026-01-02 03:59","pubTimestamp":1767297547,"startTime":"0","endTime":"0","summary":"截至2025年12月26日收盘，索宝蛋白报收于18.5元，较上周的18.63元下跌0.7%。本周，索宝蛋白12月22日盘中最高价报18.75元。本周关注点公司公告汇总：索宝蛋白拟每10股派发现金红利0.70元（含税）。截至2025年12月31日，公司总股本为191,459,105股，拟分配利润13,402,137.35元（含税），占2025年前三季度归母净利润的9.14%。若股权登记日前总股本变动，将维持每股分配比例不变，相应调整总额。会议表决结果为同意6票，反对0票，弃权0票。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010200001162.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603231","BK0238"],"gpt_icon":0},{"id":"2594024799","title":"每周股票复盘：索宝蛋白（603231）变更募投项目实施主体","url":"https://stock-news.laohu8.com/highlight/detail?id=2594024799","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594024799?lang=zh_cn&edition=full","pubTime":"2025-12-28 05:09","pubTimestamp":1766869751,"startTime":"0","endTime":"0","summary":"截至2025年12月26日收盘，索宝蛋白报收于18.5元，较上周的18.63元下跌0.7%。本周，索宝蛋白12月22日盘中最高价报18.75元。本周关注点公司公告汇总：索宝蛋白将原大豆颗粒蛋白项目变更为高端大豆分离蛋白生产线改造项目，实施主体变更为山东万得福生物科技有限公司。公司公告汇总宁波索宝蛋白科技股份有限公司于2023年12月完成首次公开发行，募集资金净额97,945.57万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122800001382.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603231","BK0238"],"gpt_icon":0},{"id":"2593876499","title":"索宝蛋白（603231）披露开立募集资金专项账户并签订四方监管协议公告，12月23日股价下跌0.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2593876499","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593876499?lang=zh_cn&edition=full","pubTime":"2025-12-23 17:58","pubTimestamp":1766483936,"startTime":"0","endTime":"0","summary":"截至2025年12月23日收盘，索宝蛋白报收于18.56元，较前一交易日下跌0.32%，最新总市值为35.53亿元。该股当日开盘18.61元，最高18.71元，最低18.51元，成交额达2700.78万元，换手率为1.37%。近日，宁波索宝蛋白科技股份有限公司发布关于开立募集资金专项账户并签订募集资金存储四方监管协议的公告。公告显示，公司于2023年12月完成首次公开发行，募集资金净额97,945.57万元。专户资金使用受严格监管，超5000万元或达募集资金净额20%的支出需及时通知保荐人。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122300029438.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603231","BK0238"],"gpt_icon":0},{"id":"2589334778","title":"12月8日索宝蛋白发布公告，股东减持29.8万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2589334778","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589334778?lang=zh_cn&edition=full","pubTime":"2025-12-08 19:01","pubTimestamp":1765191695,"startTime":"0","endTime":"0","summary":"证券之星消息，12月8日索宝蛋白发布公告《索宝蛋白:关于持股5%以上股东权益变动触及1%刻度的提示性公告》，其股东上海复星创富投资管理股份有限公司-宁波梅山保税港区复星惟盈股权投资基金合伙企业、济南财金复星惟实股权投资基金合伙企业于2025年12月4日至2025年12月5日间合计减持29.8万股，占公司目前总股本的0.1556%，变动期间该股股价下跌1.57%，截止12月5日收盘报19.42元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120800025187.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603231","BK0238"],"gpt_icon":0},{"id":"1154783475","title":"索宝蛋白股东计划减持股份","url":"https://stock-news.laohu8.com/highlight/detail?id=1154783475","media":"投资观察","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1154783475?lang=zh_cn&edition=full","pubTime":"2025-11-20 01:22","pubTimestamp":1763572943,"startTime":"0","endTime":"0","summary":"11月11日，索宝蛋白技术有限公司（603231.SS）宣布，股东们计划减持公司总计约3%的股份。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0238","603231"],"gpt_icon":0},{"id":"2584621793","title":"索宝蛋白（603231）披露取消监事会及修改公司章程议案获通过，11月17日股价下跌0.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584621793","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584621793?lang=zh_cn&edition=full","pubTime":"2025-11-17 22:26","pubTimestamp":1763389587,"startTime":"0","endTime":"0","summary":"截至2025年11月17日收盘，索宝蛋白报收于21.08元，较前一交易日下跌0.71%，最新总市值为40.36亿元。该股当日开盘21.2元，最高21.4元，最低20.88元，成交额达6248.1万元，换手率为2.8%。近日，宁波索宝蛋白科技股份有限公司召开2025年第一次临时股东大会，会议审议通过了关于取消监事会、修改《公司章程》的议案，以及修订公司多项管理制度的议案，包括《股东会议事规则》《董事会议事规则》《募集资金管理制度》等。所有议案均获有效通过，表决结果合法有效。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111700037118.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0238","603231"],"gpt_icon":0},{"id":"2583965166","title":"每周股票复盘：索宝蛋白（603231）拟取消监事会并变更募投项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2583965166","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583965166?lang=zh_cn&edition=full","pubTime":"2025-11-16 03:30","pubTimestamp":1763235037,"startTime":"0","endTime":"0","summary":"截至2025年11月14日收盘，索宝蛋白报收于21.23元，较上周的20.19元上涨5.15%。本周关注点公司公告汇总：索宝蛋白拟取消监事会，职权由董事会审计委员会行使。股东减持股份计划公告宁波索宝蛋白科技股份有限公司股东济南复星和宁波复星合计持有公司股份14.074%，因自身资金需求，拟通过集中竞价或大宗交易方式减持合计不超过5,743,772股，即不超过公司总股本的3%。本次减持不会导致公司控制权变更。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111600000848.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0238","603231"],"gpt_icon":0},{"id":"2582732170","title":"索宝蛋白（603231）披露股东减持股份计划公告，11月12日股价下跌1.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2582732170","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582732170?lang=zh_cn&edition=full","pubTime":"2025-11-12 17:35","pubTimestamp":1762940131,"startTime":"0","endTime":"0","summary":"截至2025年11月12日收盘，索宝蛋白报收于21.66元，较前一交易日下跌1.77%，最新总市值为41.47亿元。该股当日开盘21.25元，最高21.78元，最低21.22元，成交额达1.42亿元，换手率为6.24%。公司近日发布公告称，宁波索宝蛋白科技股份有限公司股东济南复星和宁波复星合计持有公司股份14.074%，因自身资金需求，拟通过集中竞价或大宗交易方式减持合计不超过5,743,772股，即不超过公司总股本的3%。本次减持不会导致公司控制权变更。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111200028752.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0238","603231"],"gpt_icon":0},{"id":"2582436532","title":"索宝蛋白(603231.SH)：济南复星、宁波复星拟合计减持不超3%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2582436532","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582436532?lang=zh_cn&edition=full","pubTime":"2025-11-11 19:53","pubTimestamp":1762861980,"startTime":"0","endTime":"0","summary":"智通财经APP讯，索宝蛋白(603231.SH)发布公告，济南复星、宁波复星拟通过集中竞价或大宗交易方式减持公司股份合计不超过574.38万股，即不超过公司总股本的3%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1367923.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["603231","BK0238"],"gpt_icon":0},{"id":"2582870576","title":"索宝蛋白（603231）披露拟取消监事会并变更部分募投项目，11月10日股价上涨1.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2582870576","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582870576?lang=zh_cn&edition=full","pubTime":"2025-11-10 22:44","pubTimestamp":1762785861,"startTime":"0","endTime":"0","summary":"截至2025年11月10日收盘，索宝蛋白报收于20.57元，较前一交易日上涨1.88%，最新总市值为39.38亿元。该股当日开盘20.19元，最高20.75元，最低20.04元，成交额达8089.23万元，换手率为3.73%。公司近日发布公告称，宁波索宝蛋白科技股份有限公司拟取消监事会，监事会职权由董事会审计委员会行使，并修改《公司章程》。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111000035006.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603231","BK0238"],"gpt_icon":0},{"id":"2580730542","title":"索宝蛋白：截至2025年10月31日，公司股东人数为17895户","url":"https://stock-news.laohu8.com/highlight/detail?id=2580730542","media":"证券日报 ","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580730542?lang=zh_cn&edition=full","pubTime":"2025-11-04 21:36","pubTimestamp":1762263360,"startTime":"0","endTime":"0","summary":"证券日报网讯索宝蛋白11月4日在互动平台回答投资者提问时表示，截至2025年10月31日，公司股东人数为17，895户。（文章来源：证券日报）\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2025-11-04/doc-infwhekh9765296.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-11-04/doc-infwhekh9765296.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0238","603231"],"gpt_icon":0},{"id":"2580523774","title":"股市必读：索宝蛋白三季报 - 第三季度单季净利润同比增长135.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2580523774","media":"中金财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580523774?lang=zh_cn&edition=full","pubTime":"2025-11-03 08:04","pubTimestamp":1762128290,"startTime":"0","endTime":"0","summary":"财务报告索宝蛋白2025年三季报显示，前三季度主营收入12.4亿元，同比上升7.37%；归母净利润1.47亿元，同比上升60.0%；扣非净利润1.42亿元，同比上升74.37%。2025年第三季度单季度主营收入4.66亿元，同比上升21.75%；单季度归母净利润4925.55万元，同比上升135.87%；单季度扣非净利润4862.25万元，同比上升172.86%。第三届监事会第五次会议决议公告宁波索宝蛋白科技股份有限公司第三届监事会第五次会议于2025年10月30日召开，应出席监事3名，实际出席3名，会议合法有效。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20251103/31760028.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["603231"],"gpt_icon":0},{"id":"2580408505","title":"每周股票复盘：索宝蛋白（603231）Q3净利增135.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2580408505","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580408505?lang=zh_cn&edition=full","pubTime":"2025-11-02 08:49","pubTimestamp":1762044548,"startTime":"0","endTime":"0","summary":"截至2025年10月31日收盘，索宝蛋白报收于20.29元，较上周的19.29元上涨5.18%。本周，索宝蛋白10月31日盘中最高价报20.56元。股本股东变化截至2025年9月30日，索宝蛋白股东户数为1.9万户，较9月19日减少762户，减幅3.86%。第三季度单季度主营收入4.66亿元，同比增长21.75%；归母净利润4925.55万元，同比增长135.87%；扣非净利润4862.25万元，同比增长172.86%。项目总投资17,000万元，建设期19个月，达产后预计年均税后利润3,200万元，税后内部收益率26.27%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110200001930.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0238","603231"],"gpt_icon":0},{"id":"2579459709","title":"索宝蛋白(603231)9月30日股东户数1.9万户，较上期减少3.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579459709","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579459709?lang=zh_cn&edition=full","pubTime":"2025-10-31 17:28","pubTimestamp":1761902924,"startTime":"0","endTime":"0","summary":"证券之星消息，近日索宝蛋白披露，截至2025年9月30日公司股东户数为1.9万户，较9月19日减少762.0户，减幅为3.86%。在农产品加工行业个股中，索宝蛋白股东户数低于行业平均水平，截至9月30日，农产品加工行业平均股东户数为3.44万户。从股价来看，2025年9月19日至2025年9月30日，索宝蛋白区间涨幅为0.05%，在此期间股东户数减少762.0户，减幅为3.86%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103100036451.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0238","603231"],"gpt_icon":0},{"id":"2579175332","title":"图解索宝蛋白三季报：第三季度单季净利润同比增长135.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579175332","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579175332?lang=zh_cn&edition=full","pubTime":"2025-10-31 02:32","pubTimestamp":1761849144,"startTime":"0","endTime":"0","summary":"证券之星消息，索宝蛋白2025年三季报显示，前三季度公司主营收入12.4亿元，同比上升7.37%；归母净利润1.47亿元，同比上升60.0%；扣非净利润1.42亿元，同比上升74.37%；其中2025年第三季度，公司单季度主营收入4.66亿元，同比上升21.75%；单季度归母净利润4925.55万元，同比上升135.87%；单季度扣非净利润4862.25万元，同比上升172.86%；负债率9.67%，投资收益158.2万元，财务费用-404.51万元，毛利率17.91%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103100002891.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603231"],"gpt_icon":0},{"id":"2577387466","title":"异动快报：索宝蛋白（603231）10月22日9点39分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2577387466","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577387466?lang=zh_cn&edition=full","pubTime":"2025-10-22 09:40","pubTimestamp":1761097244,"startTime":"0","endTime":"0","summary":"证券之星10月22日盘中消息，9点39分索宝蛋白（603231）触及涨停板。目前价格20.86，上涨10.02%。其所属行业农产品加工目前上涨。领涨股为双塔食品。该股为人造肉，合成生物概念热股，当日人造肉概念上涨2.0%。10月21日的资金流向数据方面，主力资金净流出409.92万元，占总成交额7.2%，游资资金净流出47.9万元，占总成交额0.84%，散户资金净流入457.82万元，占总成交额8.04%。近5日资金流向一览见下表：索宝蛋白主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102200009090.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0238","603231"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1768333154017,"stockEarnings":[{"period":"1week","weight":0.0189},{"period":"1month","weight":0.0233},{"period":"3month","weight":-0.0079},{"period":"6month","weight":0.1085},{"period":"1year","weight":0.2061},{"period":"ytd","weight":0.0317}],"compareEarnings":[{"period":"1week","weight":0.0135},{"period":"1month","weight":0.0641},{"period":"3month","weight":0.0579},{"period":"6month","weight":0.1768},{"period":"1year","weight":0.3094},{"period":"ytd","weight":0.0428}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"宁波索宝蛋白科技股份有限公司","boardCode":"AI0013","boardName":"农副食品加工业","stockholders":"16513人(较上一季度增加2.94%)","perCapita":"6435股","listingDate":"2023-12-15","address":"浙江省宁波市北仑区保税区兴业大道12号","registeredCapital":"19145万元","survey":" 宁波索宝蛋白科技股份有限公司的主营业务是大豆蛋白系列产品的研发、生产和销售。公司的主要产品是大豆分离蛋白、大豆浓缩蛋白、组织化蛋白、大豆膳食纤维及非转基因大豆油。","listedPrice":21.29},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"索宝蛋白(603231)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供索宝蛋白(603231)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"索宝蛋白,603231,索宝蛋白股票,索宝蛋白股票老虎,索宝蛋白股票老虎国际,索宝蛋白行情,索宝蛋白股票行情,索宝蛋白股价,索宝蛋白股市,索宝蛋白股票价格,索宝蛋白股票交易,索宝蛋白股票购买,索宝蛋白股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"索宝蛋白(603231)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供索宝蛋白(603231)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}